GLRA
AGN

Gerald L. Ray & Associates’s Allergan plc AGN Stock Holding History

Gerald L. Ray & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$778K Sell
3,797
-100
-3% -$23.3K 0.1% 176
2017
Q2 		$947K Buy
3,897
+1,467
+60% +$345K 0.12% 161
2017
Q1 		$581K Buy
2,430
+700
+40% +$163K 0.08% 206
2016
Q4 		$363K Sell
1,730
-791
-31% -$164K 0.05% 239
2016
Q3 		$581K Buy
2,521
+501
+25% +$122K 0.09% 191
2016
Q2 		$467K Buy
+2,020
New +$466K 0.07% 203
2014
Q3 		– Sell
-1,508
Closed -$336K – 308
2014
Q2 		$336K Buy
1,508
+36
+2% +$7.45K 0.06% 238
2014
Q1 		$303K Hold
1,472
– – 0.05% 242
2013
Q4 		$247K Buy
+1,472
New +$230K 0.05% 250

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Gerald L. Ray & Associates's AGN Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its Allergan plc (AGN) stake by 2.6% in Q3 2017, selling an estimated $23.3K and leaving 3,797 shares worth $778K. The position accounts for 0.1% of the portfolio, ranked #176.

Gerald L. Ray & Associates first reported a position in AGN in Q4 2013 and has held it in 9 quarters since. The position peaked at $947K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Gerald L. Ray & Associates held 3,797 shares of Allergan plc worth $778K as of Q3 2017.
  • Gerald L. Ray & Associates sold 100 Allergan plc shares in Q3 2017, an estimated $23.3K.
  • Allergan plc made up 0.1% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #176 holding.
  • Gerald L. Ray & Associates first reported a position in Allergan plc in Q4 2013 and has held it in 9 quarters since.
  • Gerald L. Ray & Associates's Allergan plc position peaked at $947K in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.